Chemotherapy Market Estimation, Dynamics, Top Companies, Size, Competitor Analysis and Opportunity Assessment 2019-2023
Apr 10, 2019
This report studies the Global Chemotherapy Market status and outlook of Global Market 2019. The report begins with the overview of Industry Chain structure, and describes industry environment, then analyses market size and...
Pune, India - April 10, 2019 /MarketersMedia/ —
Market Scenario:
According to the analysis offered by Market Research Future (MRFR), the global chemotherapy market has been presumed to strike a CAGR of 6.2% during the forecast period 2017 to 2023. Chemotherapy is an effective treatment for cancer which infuses drugs into the bloodstream to target specific cancer sites. The growth trajectory of the market is anticipated to be dominated by the rising burden of the disease.
Chemotherapy is excessively used for the treatment of different types of cancer such as lung cancer, bone cancer, blood cancer, etc. The technological advancements in the treatment are further expected to boost the future trajectory of the chemotherapy market.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5791
Emphasis is placed on research & development for bringing more precision and effectiveness. It is prognosticated to have a favorable impact on the expansion of the chemotherapy market. On the flip side, factors such as the high cost of treatment and poor reimbursement policies remain impediments to the market growth. In addition, the side effects of the treatment such as hair loss, hearing impairment, alopecia, etc. are projected to further hinder the proliferation of the chemotherapy market in the upcoming years.
Competitive Dashboard:
Some of the key players profiled in this MRFR report are Sanofi (France), Eli Lilly & Company (U.S.), GlaxoSmithKline (U.K.), Novartis (Germany), Pfizer Inc. (U.S.), ImClone Systems Inc. (U.S.), AstraZeneca (U.K), Schering-Plough (U.S.), Bristol-Myers Squibb , Teva Pharmaceuticals Industries (Japan), F. Hoffmann-La Roche Ltd ( Switzerland), Boehringer Ingelheim (Germany), Merck & Co., Inc. (U.S.), CELGENE CORPORATION (U.S.), Amgen Inc (U.S.), Chemo Espana SL (Spain), Bayer AG (Germany), and Takeda Pharmaceutical Company Limited (Japan).
Industry News:
In May 2018, Advanced Chemotherapy Technologies, North Carolina, has started working on large coin-sized implant for delivering chemo agents into the pancreas.
In September 2018, Alan B. Pearson Regional Cancer Center in Lynchburg announced the installation of Dignicap Cooling System that cools down the scalp by 37 degrees for preventing hair loss during chemotherapy.
In December 2018, a team of experts is reported to work on the development of dry powder for inhaled chemotherapy. The Belgian spin-off project, InhaTarget Therapeutics, aims at treating lung cancer locally.
Market Segmentation:
On the basis of drugs, the global chemotherapy market has been segmented into anti-tumor antibiotics, topoisomerase inhibitors, alkylating agents, antimetabolites, mitotic inhibitors, and others. The alkylating agents segment has been further sub-segmented into mustard gas derivatives, ethylenimines, alkyl sulfonates, hydrazines and triazines, and others. The anti-tumor antibiotics segment is further sub-segmented into anthracyclines and chromomycin. The topoisomerase inhibitors segment has been sub-segmented into Topoisomerase I inhibitors and Topoisomerase II inhibitors.
On the basis of indication, the chemotherapy market has been segmented into lymphoma, leukemia, breast cancer, lung cancer, myeloma, ovarian cancer, sarcoma, and others.
On the basis of the route of drug administration, the global chemotherapy market has been segmented into oral and intravenous.
On the basis of end-user, the chemotherapy market has been segmented into hospitals, research institutes, and others.
Regional Analysis:
By region, the global chemotherapy market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is expected to thrive significantly in the foreseeable future. The rising burden of cancer is poised to dive the expansion of the chemotherapy market in the region over the assessment period. Other factors that are likely to propel the expansion of the regional market are changing lifestyle, advancements in healthcare, rising healthcare expenditure, etc.
Europe is projected to witness considerable growth owing to the availability of funds and government support for research & development. Also, Asia Pacific is likely to flourish during the projection period due to rapid developments in the healthcare sector. It is estimated to strike a comparatively higher CAGR across the review period. Meanwhile, the Middle East & Africa resonates growth opportunities owing to the increasing awareness about the disease.
Browse Complete 100 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/chemotherapy-market-5791
Detailed Table of Contents:
Table Of Contents
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity Of Competitor’s
4.1.4 Threat Of New Entrants
5 Global Chemotherapy Market, By Material
5.1 Introduction
5.1.1 Synthetic Materials
5.1.2 Genetically Engineered Materials
5.1.3 Biologically Derived Materials
5.1.4 Others
...TOC Continued!
Send an Enquiry @ https://www.marketresearchfuture.com/enquiry/5791
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/chemotherapy-market-5791
Source: MarketersMedia
Release ID: 501112
More News
China’s Exports Soar, Putting Its Trade Surplus on Track for a Record
China’s exports grew last month at the fastest pace in almost any month since the end of the global financial crisis.
Russia’s Arrest of a Japanese Journalist Deepens the Freeze in Japan-Russia Relations
The case of Hokkaido Shimbun correspondent Imai Yuki could chill reporting from Russia’s Far East and narrow the space for even limited diplomatic engagement.
ASML’s chip equipment sales to China soar 109% despite US export curb push
Dutch semiconductor equipment giant ASML expects China to account for about 20 per cent of its total sales this year, after seeing shipments to the market more than double during the previous quarter despite mounting US pressure for tighter export restrictions on less advanced chipmaking machinery. The company’s sales to China surged 109 per cent in the third quarter compared with the previous three months, according to financial results released on Wednesday. That took China’s share of ASML’s...
How Australia’s Gambling Lobby has Successfully Avoided Any Reform
Political donations, lobbying, and community influence help gambling companies block major policy reforms and protect huge profits.
In Confronting China, The West Needs Partners in Southeast Asia
A plan to confront Beijing without subsequent outreach toward Southeast Asian countries will sacrifice national imperatives for willing partners, and those are hard to come by.
Philippine law targeting foreign agents spurs fears of free speech curbs
Philippine officials want a new anti-foreign interference law ahead of the 2028 presidential election, as a raid on a suspected online scam centre near the country’s military headquarters and reports of Chinese-linked money transfers to a company tied to Vice-President Sara Duterte-Carpio’s family fuel national security concerns. On Monday, immigration and military operatives arrested 76 foreigners at a facility in Quezon City suspected of being linked to Philippine offshore gaming operators...
AI risks could repeat China shock that cost jobs, former US commerce chief Raimondo warns
The rapid and unbridled development of artificial intelligence (AI) has the potential to disrupt the US economy in a way that is comparable to the “China shock” that displaced American workers, former US commerce secretary Gina Raimondo warns. Speaking at the Bloomberg New Economy Forum in New Delhi on Tuesday, she drew parallels between AI’s potential disruption to American jobs and the past impact of Chinese manufacturing competition on the US labour market. “In America, we’ve seen what...
Can the China-US Detente Last?
Competition can generate incentives for restraint, and restraint can create opportunities for further competition.
Japan Protests Russia’s Detention of Journalist Accused of Spying
Tokyo summoned Russia’s ambassador after a Japanese reporter was arrested in Russia’s far east and accused of collecting military intelligence.
China approves Alibaba AI models for use in iPhone Duo and other Apple handsets
China has granted approval for Alibaba Group Holding’s artificial intelligence models to be integrated into several Apple handsets, including the new iPhone Duo, in the Chinese market, clearing a key regulatory hurdle for the long-delayed launch of Apple Intelligence in the country. Updated network access permits for the iPhone Duo, iPhone 18 Pro and several earlier Apple models from China’s Ministry of Industry and Information Technology now include three approved AI systems: Apple Intelligence...
Chinese memory giant YMTC to grow revenue 6 times faster than peers as IPO nears: report
Yangtze Memory Technologies Corporation (YMTC), China’s leading flash-memory maker, is set to grow revenue six times faster than its industry peers this year as it expands into server-related business ahead of a planned initial public offering (IPO), according to Counterpoint Research. The company’s server-related revenue was effectively zero in 2024, but could account for nearly 39 per cent of its revenue by 2028, according to the market intelligence firm on Tuesday. Much of the momentum is...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.